Donepezil
Back to searchMolecule Structure
Scientific Name
Donepezil
Description of the Drug
Donepezil is an acetylcholinesterase inhibitor used to treat the behavioral and cognitive effects of Alzheimer’s Disease and other types of dementia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00843
http://www.drugbank.ca/drugs/DB00843
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Jubilant Generics Ltd, Sun Pharmaceutical Industries Inc, Macleods Pharmaceuticals Ltd, Osmotica Pharmaceutical Us Llc, Mylan Pharmaceuticals Inc, Corium Inc, Zydus Pharmaceuticals Usa Inc, Allergan Sales Llc, Prinston Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2149 | |||
| PharmGKB | PA449394 | |||
| Human Metabolome Database | HMDB0005041 | |||
| DrugBank | DB00843 | |||
| PubChem: Thomson Pharma | 14829295 | |||
| PubChem | 3152 | |||
| LINCS | LSM-1598 | |||
| Nikkaji | J458.527E | |||
| BindingDB | 8960 | |||
| EPA CompTox Dashboard | DTXSID8048317 | |||
| DrugCentral | 946 | |||
| Brenda | 2444 | 240553 | 80306 | 55195 |
| ChemicalBook | CB23334700 | CB0156314 | CB73050236 | CB62741796 |
| Guide to Pharmacology | 6599 | |||
| rxnorm | DONEPEZIL HYDROCHLORIDE | ARICEPT | DONEPEZIL | |
| ChEBI | 145499 | 53289 |
